{
    "arxiv_id": "2303.08245",
    "paper_title": "Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data",
    "authors": [
        "C. Wu",
        "E. B. Gunnarsson",
        "E. M. Myklebust",
        "A. KÃ¶hn-Luque",
        "D. S. Tadele",
        "J. M. Enserink",
        "A. Frigessi",
        "J. Foo",
        "K. Leder"
    ],
    "submission_date": "2023-03-14",
    "revised_dates": [
        "2023-03-16"
    ],
    "latest_version": 1,
    "categories": [
        "q-bio.PE",
        "q-bio.QM"
    ],
    "abstract": "Tumor heterogeneity is a complex and widely recognized trait that poses significant challenges in developing effective cancer therapies. Characterizing the heterogeneous subpopulation structure within a tumor will enable a more precise and successful treatment strategy for cancer therapy. A possible strategy to uncover the structure of subpopulations is to examine how they respond differently to different drugs. For instance, PhenoPop was proposed as a means to unravel the subpopulation structure within a tumor from high-throughput drug screening data. However, the deterministic nature of PhenoPop restricts the model fit and the information it can extract from the data. As an advancement, we proposed a stochastic model based on the linear birth-death process to address this limitation. Our model can formulate a dynamic variance along the horizon of the experiment so that the model uses more information from the data to provide a more robust estimation. In addition, the newly proposed model can be readily adapted to situations where the experimental data exhibits a positive time correlation. We concluded our study by testing our model on simulated data (In Silico) and experimental data (In Vitro), which supports our argument about its advantages.",
    "pdf_urls": [
        "http://arxiv.org/pdf/2303.08245v1"
    ],
    "publication_venue": null
}